Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
Is a |
Cilastatin and imipenem and relebactam only product in parenteral dose form |
true |
Inferred relationship |
Some |
|
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
Has manufactured dose form |
Powder for conventional release solution for infusion (dose form) |
true |
Inferred relationship |
Some |
|
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
Has unit of presentation |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
|
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
Plays role |
Antibacterial therapeutic role (role) |
false |
Inferred relationship |
Some |
|
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Imipenem |
true |
Inferred relationship |
Some |
1 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Imipenem |
true |
Inferred relationship |
Some |
1 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
1 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
1 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Relebactam (substance) |
true |
Inferred relationship |
Some |
2 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Relebactam (substance) |
true |
Inferred relationship |
Some |
2 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
2 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
2 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
Cilastatin sodium (substance) |
true |
Inferred relationship |
Some |
3 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
Cilastatin |
true |
Inferred relationship |
Some |
3 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the numerator unit for the presentation strength of a product. |
mg |
true |
Inferred relationship |
Some |
3 |
|
Cilastatin (as cilastatin sodium) 500 mg and imipenem 500 mg and relebactam 250 mg powder for solution for infusion vial |
This attribute specifies the denominator unit for the presentation strength of a product. |
Vial (unit of presentation) |
true |
Inferred relationship |
Some |
3 |
|